Role of autophagy and apoptosis in non-small-cell lung cancer

Guangbo Liu, Fen Pei, Fengqing Yang, Lingxiao Li, Amit Dipak Amin, Songnian Liu, J. Ross Buchan, William C. Cho

Research output: Contribution to journalReview article

67 Citations (Scopus)

Abstract

Non-small-cell lung cancer (NSCLC) constitutes 85% of all lung cancers, and is the leading cause of cancer-related death worldwide. The poor prognosis and resistance to both radiation and chemotherapy warrant further investigation into the molecular mechanisms of NSCLC and the development of new, more efficacious therapeutics. The processes of autophagy and apoptosis, which induce degradation of proteins and organelles or cell death upon cellular stress, are crucial in the pathophysiology of NSCLC. The close interplay between autophagy and apoptosis through shared signaling pathways complicates our understanding of how NSCLC pathophysiology is regulated. The apoptotic effect of autophagy is controversial as both inhibitory and stimulatory effects have been reported in NSCLC. In addition, crosstalk of proteins regulating both autophagy and apoptosis exists. Here, we review the recent advances of the relationship between autophagy and apoptosis in NSCLC, aiming to provide few insights into the discovery of novel pathogenic factors and the development of new cancer therapeutics.

Original languageEnglish (US)
Article number367
JournalInternational journal of molecular sciences
Volume18
Issue number2
DOIs
StatePublished - Feb 10 2017

Fingerprint

Autophagy
apoptosis
Cell death
Non-Small Cell Lung Carcinoma
lungs
cancer
Cells
Apoptosis
Chemotherapy
Proteins
Crosstalk
death
Radiation
Degradation
Organelles
Proteolysis
proteins
Lung Neoplasms
Neoplasms
organelles

Keywords

  • Apoptosis
  • Autophagy
  • Crosstalk
  • Endoplasmic reticulum (ER) stress
  • Mammalian target of rapamycin (mTOR)
  • Non-small-cell lung cancer (NSCLC)
  • p53

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Liu, G., Pei, F., Yang, F., Li, L., Amin, A. D., Liu, S., ... Cho, W. C. (2017). Role of autophagy and apoptosis in non-small-cell lung cancer. International journal of molecular sciences, 18(2), [367]. https://doi.org/10.3390/ijms18020367

Role of autophagy and apoptosis in non-small-cell lung cancer. / Liu, Guangbo; Pei, Fen; Yang, Fengqing; Li, Lingxiao; Amin, Amit Dipak; Liu, Songnian; Ross Buchan, J.; Cho, William C.

In: International journal of molecular sciences, Vol. 18, No. 2, 367, 10.02.2017.

Research output: Contribution to journalReview article

Liu, Guangbo ; Pei, Fen ; Yang, Fengqing ; Li, Lingxiao ; Amin, Amit Dipak ; Liu, Songnian ; Ross Buchan, J. ; Cho, William C. / Role of autophagy and apoptosis in non-small-cell lung cancer. In: International journal of molecular sciences. 2017 ; Vol. 18, No. 2.
@article{9492db0120e74f47ae0848d977735a82,
title = "Role of autophagy and apoptosis in non-small-cell lung cancer",
abstract = "Non-small-cell lung cancer (NSCLC) constitutes 85{\%} of all lung cancers, and is the leading cause of cancer-related death worldwide. The poor prognosis and resistance to both radiation and chemotherapy warrant further investigation into the molecular mechanisms of NSCLC and the development of new, more efficacious therapeutics. The processes of autophagy and apoptosis, which induce degradation of proteins and organelles or cell death upon cellular stress, are crucial in the pathophysiology of NSCLC. The close interplay between autophagy and apoptosis through shared signaling pathways complicates our understanding of how NSCLC pathophysiology is regulated. The apoptotic effect of autophagy is controversial as both inhibitory and stimulatory effects have been reported in NSCLC. In addition, crosstalk of proteins regulating both autophagy and apoptosis exists. Here, we review the recent advances of the relationship between autophagy and apoptosis in NSCLC, aiming to provide few insights into the discovery of novel pathogenic factors and the development of new cancer therapeutics.",
keywords = "Apoptosis, Autophagy, Crosstalk, Endoplasmic reticulum (ER) stress, Mammalian target of rapamycin (mTOR), Non-small-cell lung cancer (NSCLC), p53",
author = "Guangbo Liu and Fen Pei and Fengqing Yang and Lingxiao Li and Amin, {Amit Dipak} and Songnian Liu and {Ross Buchan}, J. and Cho, {William C.}",
year = "2017",
month = "2",
day = "10",
doi = "10.3390/ijms18020367",
language = "English (US)",
volume = "18",
journal = "International Journal of Molecular Sciences",
issn = "1422-0067",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",

}

TY - JOUR

T1 - Role of autophagy and apoptosis in non-small-cell lung cancer

AU - Liu, Guangbo

AU - Pei, Fen

AU - Yang, Fengqing

AU - Li, Lingxiao

AU - Amin, Amit Dipak

AU - Liu, Songnian

AU - Ross Buchan, J.

AU - Cho, William C.

PY - 2017/2/10

Y1 - 2017/2/10

N2 - Non-small-cell lung cancer (NSCLC) constitutes 85% of all lung cancers, and is the leading cause of cancer-related death worldwide. The poor prognosis and resistance to both radiation and chemotherapy warrant further investigation into the molecular mechanisms of NSCLC and the development of new, more efficacious therapeutics. The processes of autophagy and apoptosis, which induce degradation of proteins and organelles or cell death upon cellular stress, are crucial in the pathophysiology of NSCLC. The close interplay between autophagy and apoptosis through shared signaling pathways complicates our understanding of how NSCLC pathophysiology is regulated. The apoptotic effect of autophagy is controversial as both inhibitory and stimulatory effects have been reported in NSCLC. In addition, crosstalk of proteins regulating both autophagy and apoptosis exists. Here, we review the recent advances of the relationship between autophagy and apoptosis in NSCLC, aiming to provide few insights into the discovery of novel pathogenic factors and the development of new cancer therapeutics.

AB - Non-small-cell lung cancer (NSCLC) constitutes 85% of all lung cancers, and is the leading cause of cancer-related death worldwide. The poor prognosis and resistance to both radiation and chemotherapy warrant further investigation into the molecular mechanisms of NSCLC and the development of new, more efficacious therapeutics. The processes of autophagy and apoptosis, which induce degradation of proteins and organelles or cell death upon cellular stress, are crucial in the pathophysiology of NSCLC. The close interplay between autophagy and apoptosis through shared signaling pathways complicates our understanding of how NSCLC pathophysiology is regulated. The apoptotic effect of autophagy is controversial as both inhibitory and stimulatory effects have been reported in NSCLC. In addition, crosstalk of proteins regulating both autophagy and apoptosis exists. Here, we review the recent advances of the relationship between autophagy and apoptosis in NSCLC, aiming to provide few insights into the discovery of novel pathogenic factors and the development of new cancer therapeutics.

KW - Apoptosis

KW - Autophagy

KW - Crosstalk

KW - Endoplasmic reticulum (ER) stress

KW - Mammalian target of rapamycin (mTOR)

KW - Non-small-cell lung cancer (NSCLC)

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=85012226371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012226371&partnerID=8YFLogxK

U2 - 10.3390/ijms18020367

DO - 10.3390/ijms18020367

M3 - Review article

C2 - 28208579

AN - SCOPUS:85012226371

VL - 18

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1422-0067

IS - 2

M1 - 367

ER -